Harbor Osmosis国际资源效率主动型ETF EFFI 深 沪
等待开盘 07-06 09:30:00 美东时间
25.7443
+0.438
+1.73%
华盛通- 最 高25.7443
- 今 开25.66
- 成交量 95股
- 最 低 25.7443
- 昨 收 25.3059
- 总市值 1.45亿
- 52周最高 25.7443
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 21.373
- 委 比 0.00%
- 总股本 565.00万
- 历史最高 25.7443
- 量 比 0.14
- 振 幅 0.00%
- 历史最低 17.0723
- 每 手 1
- 风险率 1.16%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Australian Oil Company Announces Implementation Of Robust Cost And Operational Efficiencies In California
BRIEF-Australian Oil Company Announces Implementation Of Robust Cost And Operational Efficiencies In California June 24 (Reuters) - Australian Oil Company Ltd AOK.AX : IMPLEMENTATION OF ROBUST COST AND OPERATIONAL EFFICIENCIES IN CALIFORNIA REC BOARD WELLS TO RETURN TO PRODUCTION AFTER PIPELINE MAIN
06-24 10:19
BRIEF-Sanofi’s Sarclisa Subcutaneous Formulation Approved In Japan For Patients With Multiple Myeloma
BRIEF-Sanofi’s Sarclisa Subcutaneous Formulation Approved In Japan For Patients With Multiple Myeloma June 19 (Reuters) - Sanofi SA SASY.PA : PRESS RELEASE: SANOFI’S SARCLISA SUBCUTANEOUS FORMULATION APPROVED IN JAPAN FOR PATIENTS WITH MULTIPLE MYELOMA APPROVAL BASED ON IRAKLIA PHASE 3 STUDY SHOWING
06-19 18:33
BRIEF-Celldex Therapeutics Says Barzolvolimab Meets Primary Efficacy Endpoint In Phase 2 CSU Study
BRIEF-Celldex Therapeutics Says Barzolvolimab Meets Primary Efficacy Endpoint In Phase 2 CSU Study June 14 (Reuters) - Celldex Therapeutics Inc CLDX.O : CELLDEX PRESENTS LONG-TERM BARZOLVOLIMAB RESULTS DEMONSTRATING SUSTAINED OFF-TREATMENT IMPROVEMENT IN ANGIOEDEMA IN PATIENTS WITH CSU AT THE EUROPE
06-14 22:26
Skillsoft Q1 2027 Earnings Call: Complete Transcript
Skillsoft (NYSE:SKIL) released first-quarter financial results and hosted an ea...
06-10 05:53
BRIEF-BioPorto Initiates U.S. Adult Validation Study
BRIEF-BioPorto Initiates U.S. Adult Validation Study June 9 (Reuters) - Bioporto A/S BIOPOR.CO : TO INITIATE PRONEPHRO AKI U.S. ADULT URINE NGAL VALIDATION STUDY INITIATION FOLLOWS U.S. FOOD AND DRUG ADMINISTRATION (FDA) FEEDBACK ON PRE-SUBMISSION REQUEST FILED MARCH 31, 2026 AS A RESULT OF INCREASE
06-09 18:41
BRIEF-Pfizer Says Vesper-1 Shows Nearly 16% Weight Loss At 32 Weeks On 2.4 Mg Weekly Berobenatide
BRIEF-Pfizer Says Vesper-1 Shows Nearly 16% Weight Loss At 32 Weeks On 2.4 Mg Weekly Berobenatide June 6 (Reuters) - Pfizer Inc PFE.N : ROBUST PHASE 2B EFFICACY AND FAVORABLE TOLERABILITY SUPPORT MONTHLY DOSING FOR PFIZER’S GLP-1 RA BEROBENATIDE PFIZER - VESPER-1 SHOWS NEARLY 16% WEIGHT LOSS AT 32 W
06-06 21:04
BRIEF-Oversight Board Questions Efficacy Of Meta's Responses To Threats Of Violence
BRIEF-Oversight Board Questions Efficacy Of Meta's Responses To Threats Of Violence June 4 (Reuters) - Oversight Board: OVERSIGHT BOARD: FINDS META WAS CORRECT TO PERMANENTLY DISABLE AN ACCOUNT FOR SEVERE THREATS OF VIOLENCE IT POSTED AGAINST A JOURNALIST OVERSIGHT BOARD: QUESTIONS EFFICACY OF META’
06-04 17:46
BRIEF-Remy Cointreau needs pricing flexibility but will remain premium, CEO says
BRIEF-Remy Cointreau needs pricing flexibility but will remain premium, CEO says June 4 (Reuters) - Remy Cointreau RCOP.PA CEO Franck Marilly and deputy CEO and CFO Luca Marotta tell analysts in a call: REMY CFO: BIG PART OF OUR PROFIT TARGET WILL BE DELIVERED VIA HIGHER SALES AND EFFICIENCIES IN AP
06-04 16:31
BRIEF-Immunome Says Varegacestat Treatment Resulted In Statistically Significant Improvements In Primary And All Key Secondary Efficacy Endpoints
BRIEF-Immunome Says Varegacestat Treatment Resulted In Statistically Significant Improvements In Primary And All Key Secondary Efficacy Endpoints May 30 (Reuters) - Immunome Inc IMNM.O : IMMUNOME - VAREGACESTAT TREATMENT RESULTED IN STATISTICALLY SIGNIFICANT IMPROVEMENTS IN PRIMARY AND ALL KEY SECON
05-30 20:12
Pioneer Power Solutions Q1 revenue falls 37% on lower EV charging sales
Pioneer Power Solutions Q1 revenue falls 37% on lower EV charging sales Overview US distributed energy equipment maker's Q1 2026 revenue fell 37% yr/yr, driven by lower EV charging sales Gross margin improved to 13.6% from 2.2%, reflecting operating efficiencies in mobile EV charging Company impleme
05-18 19:39
